Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow-up for Subjects With Chronic Hepatitis C Infection Who Received Interferon-based Therapy or Direct-acting Antiviral Agents (DAAs)-Based Therapy

NCT02578693 is registered in ClinicalTrials.gov with Humanity and Health Research Centre as lead sponsor.

NCT NCT02578693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02578693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow-up for Subjects With Chronic Hepatitis C Infection Who Received Interferon-based Therapy or Direct-acting Antiviral Agents (DAAs)-Based Therapy
Lead sponsor
Humanity and Health Research Centre
Phase
Observational
Overall status
Completed
Start date
May 15, 2015
Completion date
July 31, 2024
Enrollment
1,210 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c infection